Literature DB >> 8093871

Gastric argyrophil (enterochromaffin-like), gastrin, and somatostatin cells after proximal selective vagotomy in man.

H Koop1, M Frank, S Kuly, R Nold, R Eissele, G Rager, J Rüschoff, M Rothmund, R Arnold.   

Abstract

The number, size, and volume density of endocrine cells was determined in biopsies obtained endoscopically in patients after proximal selective vagotomy (PSV; N = 31), antrectomy (N = 9), untreated duodenal ulcer (DU) disease (N = 11), and in controls (N = 15). Serum gastrin was significantly elevated after PSV (mean 60 pg/ml) compared to DU patients (29 pg/ml), controls (26 pg/ml), and after antrectomy (11 pg/ml). Volume density of fundic argyrophil (largely enterochromaffin-like) cells after PSV (0.74%) and in DU disease (0.63%) were significantly (P < 0.001) higher when compared with controls (0.37%) but lower after antrectomy (0.24%; P < 0.02). The density of argyrophil cells was not influenced by the interval following PSV or the magnitude of hypergastrinemia. Antral gastrin cells were increased after vagotomy, whereas the antral and fundic somatostatin cell numbers were reduced after PSV. It is concluded that: (1) a major role of the vagal nerve as a trophic factor for enterochromaffin-like cells could not be demonstrated after PSV, and (2) moderate hypergastrinemia after PSV did not induce proliferation of ECL cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093871     DOI: 10.1007/bf01307547

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  43 in total

1.  Gastric ECL-cell hyperplasia and carcinoids in rodents following chronic administration of H2-antagonists SK&F 93479 and oxmetidine and omeprazole.

Authors:  G R Betton; C S Dormer; T Wells; P Pert; C A Price; P Buckley
Journal:  Toxicol Pathol       Date:  1988       Impact factor: 1.902

2.  Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Studies with omeprazole and ranitidine in intact and antrectomized rats.

Authors:  H Larsson; E Carlsson; R Håkanson; H Mattsson; G Nilsson; R Seensalu; B Wallmark; F Sundler
Journal:  Gastroenterology       Date:  1988-12       Impact factor: 22.682

3.  Serum gastrin and gastric acid secretion before and after proximal gastric vagotomy.

Authors:  E Schrumpf; M Roland; I Liavåg
Journal:  Scand J Gastroenterol       Date:  1974       Impact factor: 2.423

4.  Gastrin response to insulin after selective, highly selective, and truncal vagotomy.

Authors:  F Stadil; J F Rehfeld
Journal:  Gastroenterology       Date:  1974-01       Impact factor: 22.682

5.  Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats.

Authors:  H Larsson; E Carlsson; H Mattsson; L Lundell; F Sundler; G Sundell; B Wallmark; T Watanabe; R Håkanson
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

6.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

7.  Proliferation of gastric endocrine cells after vagotomy in the rat.

Authors:  M W Mulholland; M Bonsack; J P Delaney
Journal:  Endocrinology       Date:  1985-10       Impact factor: 4.736

8.  Effects of partial resection of acid-secreting mucosa on plasma gastrin and enterochromaffin-like cells in the rat stomach.

Authors:  B Ryberg; E Carlsson; R Håkanson; L Lundell; H Mattsson; F Sundler
Journal:  Digestion       Date:  1990       Impact factor: 3.216

Review 9.  Activation and hyperplasia of gastrin and enterochromaffin-like cells in the stomach.

Authors:  R Håkanson; G Böttcher; F Sundler; S Vallgren
Journal:  Digestion       Date:  1986       Impact factor: 3.216

10.  Argyrophil cell hyperplasia associated with chronic corpus gastritis in gastric ulcer disease.

Authors:  N Havu; H I Maaroos; P Sipponen
Journal:  Scand J Gastroenterol Suppl       Date:  1991
View more
  2 in total

Review 1.  Risk-benefit assessment of omeprazole in the treatment of gastrointestinal disorders.

Authors:  W Creutzfeldt
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

Review 2.  The consequences of hypergastrinemia.

Authors:  W Creutzfeldt
Journal:  Yale J Biol Med       Date:  1994 May-Aug
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.